Otsuka Holdings Co., Ltd. (OTSKF) Research

Otsuka Holdings Co., Ltd. is a global enterprise with a diverse portfolio spanning pharmaceuticals, nutraceuticals, consumer goods, and a multitude of other industries. Its core pharmaceutical division is dedicated to developing treatments across a wide range of therapeutic areas, including psychiatry, neurology, oncology, cardiovascular and renal conditions, digestive system disorders, and ophthalmology. This segment also produces diagnostics, intravenous solutions, and various medical devices. Beyond medicine, the company offers popular nutraceutical and consumer products such as the BODYMAINTÉ line (conditioning food and beverage), EQUELLE products aimed at supporting women's health and beauty, the well-known hydration drink POCARI SWEAT, the nutritional supplement Calorie Mate, and the oral rehydration solution OS-1. Otsuka's extensive operations further encompass a remarkable array of ventures, indicating a highly diversified business model. This broad scope includes the production and provision of soft drinks, food products, wines, and industrial chemicals, alongside offerings in clinical testing equipment, cosmetics, IT solutions, logistics, and specialized materials like ceramic boards and functional films. They also develop bio-pesticides, offer venture capital services, manufacture adhesive tapes, and produce plant-based foods, among many other offerings. Uniquely, the company also operates a hotel. Otsuka Holdings Co., Ltd. was established in Tokyo, Japan, in 1921.

Open Otsuka Holdings Co., Ltd. (OTSKF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.